Praluent is a new cholesterol drug which is the first in a new class of biotech medications from Sanofi SA (SASY.PA) and Regeneron Pharmaceuticals Inc (REGN.O) that use a novel approach that lowers...
FDA Approves New Cholesterol Drug Praluent
Praluent is a new cholesterol drug which is the first in a new class of biotech medications from Sanofi SA (SASY.PA) and Regeneron Pharmaceuticals Inc (REGN.O) that use a novel approach that lowers...
